Montrago Trustees Ltd
CIK 1869331 · last filed 2025-06-06
Montrago Trustees Ltd is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider sold $122.4M of STOK on Jun 6, 2025. Across all open-market trades the lifetime net is −$608.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $116.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$116.48M
2
4
-$607.95M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STOK | 10%+ Owner | 3,906,181 | $29.82 | $116.48M | -$323.29M | 3 | 2025-06-06 |
| Akero Therapeutics, Inc. (AKRO) Delisted | 3,271,829 | $54.65 | $178.81M | -$284.66M | 1 | 2022-12-05 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-06 | STOK | Sell (S) | −12,000,000 | -$122.40M | EDGAR |
| 2024-12-27 | STOK | Sell (S) | −8,000,000 | -$92.00M | EDGAR |
| 2024-09-23 | STOK | Sell (S) | −7,750,000 | -$108.89M | EDGAR |
| 2022-12-05 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −6,544,000 | -$284.66M | EDGAR |